nodes	percent_of_prediction	percent_of_DWPC	metapath
Levonordefrin—Isoprenaline—MAPK1—multiple sclerosis	0.103	0.808	CrCbGaD
Levonordefrin—Epinephrine—TNF—multiple sclerosis	0.0246	0.192	CrCbGaD
Levonordefrin—SLC6A2—nerve—multiple sclerosis	0.0105	0.142	CbGeAlD
Levonordefrin—ADRA2A—peripheral nervous system—multiple sclerosis	0.00956	0.128	CbGeAlD
Levonordefrin—SLC6A2—brainstem—multiple sclerosis	0.00453	0.0607	CbGeAlD
Levonordefrin—ADRA1A—brainstem—multiple sclerosis	0.00421	0.0565	CbGeAlD
Levonordefrin—SLC6A2—medulla oblongata—multiple sclerosis	0.00316	0.0424	CbGeAlD
Levonordefrin—ADRA2C—medulla oblongata—multiple sclerosis	0.0028	0.0375	CbGeAlD
Levonordefrin—ADRA2C—midbrain—multiple sclerosis	0.00256	0.0343	CbGeAlD
Levonordefrin—ADRA2C—spinal cord—multiple sclerosis	0.00249	0.0335	CbGeAlD
Levonordefrin—SLC6A2—nervous system—multiple sclerosis	0.00237	0.0318	CbGeAlD
Levonordefrin—SLC6A2—central nervous system—multiple sclerosis	0.00228	0.0306	CbGeAlD
Levonordefrin—ADRA2A—medulla oblongata—multiple sclerosis	0.00223	0.0299	CbGeAlD
Levonordefrin—ADRA1A—nervous system—multiple sclerosis	0.0022	0.0296	CbGeAlD
Levonordefrin—ADRA1A—central nervous system—multiple sclerosis	0.00212	0.0285	CbGeAlD
Levonordefrin—ADRA2C—nervous system—multiple sclerosis	0.0021	0.0282	CbGeAlD
Levonordefrin—ADRA1A—cerebellum—multiple sclerosis	0.00207	0.0278	CbGeAlD
Levonordefrin—ADRA2A—midbrain—multiple sclerosis	0.00204	0.0274	CbGeAlD
Levonordefrin—ADRA2C—central nervous system—multiple sclerosis	0.00202	0.0271	CbGeAlD
Levonordefrin—ADRA2A—spinal cord—multiple sclerosis	0.00199	0.0267	CbGeAlD
Levonordefrin—ADRA2C—cerebellum—multiple sclerosis	0.00198	0.0265	CbGeAlD
Levonordefrin—SLC6A2—brain—multiple sclerosis	0.00181	0.0243	CbGeAlD
Levonordefrin—ADRA1A—brain—multiple sclerosis	0.00169	0.0226	CbGeAlD
Levonordefrin—ADRA2A—nervous system—multiple sclerosis	0.00168	0.0225	CbGeAlD
Levonordefrin—ADRA2A—central nervous system—multiple sclerosis	0.00161	0.0217	CbGeAlD
Levonordefrin—ADRA2C—brain—multiple sclerosis	0.00161	0.0215	CbGeAlD
Levonordefrin—ADRA2A—cerebellum—multiple sclerosis	0.00158	0.0212	CbGeAlD
Levonordefrin—ADRA2A—brain—multiple sclerosis	0.00128	0.0172	CbGeAlD
Levonordefrin—ADRA2B—Signaling Pathways—GPR65—multiple sclerosis	0.000939	0.00118	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—CCR2—multiple sclerosis	0.000937	0.00117	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—PTGER4—multiple sclerosis	0.000931	0.00117	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—GPC5—multiple sclerosis	0.000925	0.00116	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—RGS1—multiple sclerosis	0.000925	0.00116	CbGpPWpGaD
Levonordefrin—ADRA2B—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	0.00092	0.00115	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR ligand binding—POMC—multiple sclerosis	0.000919	0.00115	CbGpPWpGaD
Levonordefrin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000916	0.00115	CbGpPWpGaD
Levonordefrin—ADRA2B—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	0.000902	0.00113	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—CXCR3—multiple sclerosis	0.0009	0.00113	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR ligand binding—CCL2—multiple sclerosis	0.0009	0.00113	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000897	0.00112	CbGpPWpGaD
Levonordefrin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000896	0.00112	CbGpPWpGaD
Levonordefrin—ADRA2A—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	0.000895	0.00112	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR ligand binding—CCR5—multiple sclerosis	0.000893	0.00112	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR downstream signaling—CNR1—multiple sclerosis	0.000889	0.00112	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—S1PR1—multiple sclerosis	0.000884	0.00111	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—GPR65—multiple sclerosis	0.000877	0.0011	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—CCR2—multiple sclerosis	0.000875	0.0011	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000866	0.00109	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—CNR1—multiple sclerosis	0.000865	0.00108	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—GPC5—multiple sclerosis	0.00086	0.00108	CbGpPWpGaD
Levonordefrin—ADRA2C—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	0.000859	0.00108	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—CXCL13—multiple sclerosis	0.000859	0.00108	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—CCR1—multiple sclerosis	0.000859	0.00108	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR ligand binding—POMC—multiple sclerosis	0.000859	0.00108	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000857	0.00107	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—RRM1—multiple sclerosis	0.000852	0.00107	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—CCL3—multiple sclerosis	0.000846	0.00106	CbGpPWpGaD
Levonordefrin—ADRA2C—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	0.000843	0.00106	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—CCR2—multiple sclerosis	0.000842	0.00106	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR ligand binding—CCL2—multiple sclerosis	0.00084	0.00105	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000833	0.00104	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—PTGER4—multiple sclerosis	0.000814	0.00102	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—RGS1—multiple sclerosis	0.000809	0.00101	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—CNR1—multiple sclerosis	0.000808	0.00101	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000805	0.00101	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—CXCL13—multiple sclerosis	0.000802	0.00101	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—CCR1—multiple sclerosis	0.000802	0.00101	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000801	0.001	CbGpPWpGaD
Levonordefrin—ADRA2A—Hemostasis—IL2RA—multiple sclerosis	0.000787	0.000986	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—CXCR3—multiple sclerosis	0.000786	0.000986	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—CCL3—multiple sclerosis	0.000786	0.000986	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—CCR2—multiple sclerosis	0.000783	0.000982	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—CXCL10—multiple sclerosis	0.000778	0.000976	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—CNR1—multiple sclerosis	0.000777	0.000975	CbGpPWpGaD
Levonordefrin—SLC6A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	0.000773	0.000969	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—GPR65—multiple sclerosis	0.000767	0.000962	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—CCR2—multiple sclerosis	0.000765	0.000959	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—PTGER4—multiple sclerosis	0.000757	0.000949	CbGpPWpGaD
Levonordefrin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	0.000753	0.000944	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—RGS1—multiple sclerosis	0.000752	0.000942	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR ligand binding—POMC—multiple sclerosis	0.000751	0.000941	CbGpPWpGaD
Levonordefrin—ADRA2B—Hemostasis—ALB—multiple sclerosis	0.00075	0.00094	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR downstream signaling—CCL5—multiple sclerosis	0.000738	0.000925	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR ligand binding—CCL2—multiple sclerosis	0.000735	0.000921	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—CXCR3—multiple sclerosis	0.000731	0.000916	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—CXCL10—multiple sclerosis	0.000727	0.000912	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—CNR1—multiple sclerosis	0.000722	0.000906	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—GPR65—multiple sclerosis	0.000712	0.000893	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—CCR2—multiple sclerosis	0.000711	0.000891	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—CNR1—multiple sclerosis	0.000706	0.000885	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—CCR1—multiple sclerosis	0.000701	0.000879	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—CXCL13—multiple sclerosis	0.000701	0.000879	CbGpPWpGaD
Levonordefrin—ADRA2C—Hemostasis—ALB—multiple sclerosis	0.0007	0.000878	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—CXCL10—multiple sclerosis	0.0007	0.000878	CbGpPWpGaD
Levonordefrin—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	0.000698	0.000875	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR ligand binding—POMC—multiple sclerosis	0.000698	0.000875	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR downstream signaling—CCL5—multiple sclerosis	0.000689	0.000864	CbGpPWpGaD
Levonordefrin—ADRA2A—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	0.000684	0.000858	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR ligand binding—CCL2—multiple sclerosis	0.000683	0.000856	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—CCL5—multiple sclerosis	0.00067	0.00084	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR downstream signaling—CCR5—multiple sclerosis	0.000665	0.000834	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—CNR1—multiple sclerosis	0.000656	0.000823	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000655	0.000822	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—CCR1—multiple sclerosis	0.000652	0.000817	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—CXCL13—multiple sclerosis	0.000652	0.000817	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—CXCL10—multiple sclerosis	0.00065	0.000816	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—CXCL10—multiple sclerosis	0.000636	0.000797	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—CCL5—multiple sclerosis	0.000626	0.000785	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR downstream signaling—CCR5—multiple sclerosis	0.000621	0.000779	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000612	0.000767	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—CCL3—multiple sclerosis	0.000612	0.000767	CbGpPWpGaD
Levonordefrin—ADRA2B—Hemostasis—IL2—multiple sclerosis	0.000608	0.000762	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—CCR5—multiple sclerosis	0.000604	0.000757	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—CCL5—multiple sclerosis	0.000603	0.000756	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—BCHE—multiple sclerosis	0.000603	0.000756	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—IL2RA—multiple sclerosis	0.000595	0.000746	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—CXCL10—multiple sclerosis	0.000591	0.000741	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—PTGER4—multiple sclerosis	0.000589	0.000739	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—PGR—multiple sclerosis	0.00058	0.000727	CbGpPWpGaD
Levonordefrin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	0.000579	0.000726	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—CCL3—multiple sclerosis	0.000572	0.000717	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—CXCR3—multiple sclerosis	0.000569	0.000713	CbGpPWpGaD
Levonordefrin—ADRA2A—Hemostasis—ALB—multiple sclerosis	0.000569	0.000713	CbGpPWpGaD
Levonordefrin—ADRA2C—Hemostasis—IL2—multiple sclerosis	0.000568	0.000712	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—CCR5—multiple sclerosis	0.000564	0.000707	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—CD28—multiple sclerosis	0.000564	0.000707	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—CCL5—multiple sclerosis	0.00056	0.000702	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—IL2RA—multiple sclerosis	0.000556	0.000697	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—CCR2—multiple sclerosis	0.000553	0.000694	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—PTGER4—multiple sclerosis	0.00055	0.00069	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—CCL5—multiple sclerosis	0.000547	0.000686	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—CCR5—multiple sclerosis	0.000543	0.000681	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—PGR—multiple sclerosis	0.000542	0.00068	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000535	0.000671	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—CXCR3—multiple sclerosis	0.000531	0.000666	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—CD28—multiple sclerosis	0.000526	0.00066	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR downstream signaling—POMC—multiple sclerosis	0.00052	0.000652	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—CCR2—multiple sclerosis	0.000517	0.000648	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—CNR1—multiple sclerosis	0.000511	0.00064	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—CCL5—multiple sclerosis	0.000508	0.000638	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—CCR5—multiple sclerosis	0.000504	0.000633	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—CCL3—multiple sclerosis	0.0005	0.000627	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000497	0.000623	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—CCR5—multiple sclerosis	0.000493	0.000618	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—BCHE—multiple sclerosis	0.000489	0.000614	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—IL2RA—multiple sclerosis	0.000486	0.000609	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR downstream signaling—POMC—multiple sclerosis	0.000485	0.000609	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—PTGER4—multiple sclerosis	0.000481	0.000603	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—CNR1—multiple sclerosis	0.000477	0.000598	CbGpPWpGaD
Levonordefrin—ADRA2B—Hemostasis—TGFB1—multiple sclerosis	0.000474	0.000595	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—PGR—multiple sclerosis	0.000474	0.000594	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—POMC—multiple sclerosis	0.000472	0.000592	CbGpPWpGaD
Levonordefrin—ADRA2B—Hemostasis—MAPK1—multiple sclerosis	0.000465	0.000583	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—CXCR3—multiple sclerosis	0.000465	0.000583	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—CCL3—multiple sclerosis	0.000464	0.000582	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—CCL2—multiple sclerosis	0.000462	0.000579	CbGpPWpGaD
Levonordefrin—ADRA2A—Hemostasis—IL2—multiple sclerosis	0.000461	0.000578	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—CD28—multiple sclerosis	0.00046	0.000577	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—CXCL10—multiple sclerosis	0.00046	0.000577	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—CCR5—multiple sclerosis	0.000458	0.000574	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—CCR2—multiple sclerosis	0.000452	0.000567	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—IL2RA—multiple sclerosis	0.000451	0.000566	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—PTGER4—multiple sclerosis	0.000447	0.00056	CbGpPWpGaD
Levonordefrin—ADRA2C—Hemostasis—TGFB1—multiple sclerosis	0.000443	0.000555	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—POMC—multiple sclerosis	0.000441	0.000553	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—PGR—multiple sclerosis	0.00044	0.000552	CbGpPWpGaD
Levonordefrin—ADRA2C—Hemostasis—MAPK1—multiple sclerosis	0.000434	0.000545	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—CXCR3—multiple sclerosis	0.000432	0.000541	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—CCL2—multiple sclerosis	0.000431	0.000541	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—CXCL10—multiple sclerosis	0.00043	0.000539	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—CD28—multiple sclerosis	0.000428	0.000536	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—POMC—multiple sclerosis	0.000424	0.000532	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—CCR2—multiple sclerosis	0.00042	0.000527	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—TYK2—multiple sclerosis	0.000419	0.000526	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—CNR1—multiple sclerosis	0.000417	0.000523	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—CD86—multiple sclerosis	0.000402	0.000504	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—CCL5—multiple sclerosis	0.000396	0.000496	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—POMC—multiple sclerosis	0.000394	0.000494	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—TYK2—multiple sclerosis	0.000392	0.000491	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—CNR1—multiple sclerosis	0.000388	0.000486	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—POMC—multiple sclerosis	0.000385	0.000483	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR downstream signaling—IL2—multiple sclerosis	0.000384	0.000482	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—CCL2—multiple sclerosis	0.000377	0.000473	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—CD86—multiple sclerosis	0.000376	0.000471	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—CXCL10—multiple sclerosis	0.000376	0.000471	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—CCL5—multiple sclerosis	0.00037	0.000464	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—SPP1—multiple sclerosis	0.000367	0.00046	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—APOE—multiple sclerosis	0.000362	0.000455	CbGpPWpGaD
Levonordefrin—ADRA2A—Hemostasis—TGFB1—multiple sclerosis	0.00036	0.000451	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR downstream signaling—IL2—multiple sclerosis	0.000359	0.00045	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—POMC—multiple sclerosis	0.000358	0.000449	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—CCR5—multiple sclerosis	0.000357	0.000447	CbGpPWpGaD
Levonordefrin—ADRA2A—Hemostasis—MAPK1—multiple sclerosis	0.000353	0.000442	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—IL2RA—multiple sclerosis	0.000351	0.000441	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—CCL2—multiple sclerosis	0.00035	0.000439	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—CXCL10—multiple sclerosis	0.000349	0.000438	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—IL2—multiple sclerosis	0.000349	0.000437	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—SPP1—multiple sclerosis	0.000342	0.000429	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—TYK2—multiple sclerosis	0.000342	0.000429	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—CCR5—multiple sclerosis	0.000333	0.000418	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—CD86—multiple sclerosis	0.000328	0.000412	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—IL2RA—multiple sclerosis	0.000328	0.000412	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—IL2—multiple sclerosis	0.000326	0.000409	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—APOE—multiple sclerosis	0.000324	0.000407	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—CCL5—multiple sclerosis	0.000323	0.000405	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—TYK2—multiple sclerosis	0.000318	0.000399	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—IL2—multiple sclerosis	0.000314	0.000393	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—POMC—multiple sclerosis	0.000311	0.00039	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—CD86—multiple sclerosis	0.000305	0.000383	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—APOE—multiple sclerosis	0.000303	0.00038	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—CCL5—multiple sclerosis	0.0003	0.000377	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—SPP1—multiple sclerosis	0.000299	0.000375	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—APOE—multiple sclerosis	0.000294	0.000369	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—CD80—multiple sclerosis	0.000293	0.000368	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—IL2—multiple sclerosis	0.000291	0.000365	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—CCR5—multiple sclerosis	0.000291	0.000365	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—IL2RA—multiple sclerosis	0.000287	0.00036	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—IL2—multiple sclerosis	0.000285	0.000357	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—ALB—multiple sclerosis	0.000284	0.000356	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—POMC—multiple sclerosis	0.000279	0.00035	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—SPP1—multiple sclerosis	0.000278	0.000349	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—CD80—multiple sclerosis	0.000274	0.000344	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—CCL2—multiple sclerosis	0.000273	0.000342	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—CCR5—multiple sclerosis	0.000271	0.000339	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—MAPK1—multiple sclerosis	0.000267	0.000335	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—IL2RA—multiple sclerosis	0.000267	0.000334	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—APOE—multiple sclerosis	0.000265	0.000332	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—IL2—multiple sclerosis	0.000265	0.000332	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—POMC—multiple sclerosis	0.00026	0.000326	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—CCL2—multiple sclerosis	0.000255	0.000319	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—POMC—multiple sclerosis	0.000253	0.000317	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—MAPK1—multiple sclerosis	0.000249	0.000313	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—TYK2—multiple sclerosis	0.000248	0.000311	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—APOE—multiple sclerosis	0.000246	0.000309	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—CD80—multiple sclerosis	0.00024	0.0003	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—TYK2—multiple sclerosis	0.000231	0.00029	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—ALB—multiple sclerosis	0.000231	0.000289	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—POMC—multiple sclerosis	0.000228	0.000285	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—CCL2—multiple sclerosis	0.000223	0.000279	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—CD80—multiple sclerosis	0.000223	0.000279	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—MAPK1—multiple sclerosis	0.000218	0.000273	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—POMC—multiple sclerosis	0.000211	0.000265	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—CCL2—multiple sclerosis	0.000207	0.000259	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—IL2—multiple sclerosis	0.000206	0.000258	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—IL6—multiple sclerosis	0.000205	0.000257	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—MAPK1—multiple sclerosis	0.000202	0.000254	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—TYK2—multiple sclerosis	0.000202	0.000254	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—MMP9—multiple sclerosis	0.000195	0.000245	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—IL2—multiple sclerosis	0.000192	0.000241	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—IL6—multiple sclerosis	0.000192	0.00024	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—TYK2—multiple sclerosis	0.000188	0.000236	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—MMP9—multiple sclerosis	0.000182	0.000228	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—STAT3—multiple sclerosis	0.000173	0.000217	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—IL2—multiple sclerosis	0.000168	0.000211	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—IL6—multiple sclerosis	0.000167	0.00021	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—STAT3—multiple sclerosis	0.000162	0.000203	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—MYC—multiple sclerosis	0.000161	0.000202	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—TGFB1—multiple sclerosis	0.000161	0.000202	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—MMP9—multiple sclerosis	0.000159	0.0002	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—MAPK1—multiple sclerosis	0.000158	0.000198	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—IL2—multiple sclerosis	0.000156	0.000196	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—IL6—multiple sclerosis	0.000156	0.000195	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—MYC—multiple sclerosis	0.000151	0.000189	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—TGFB1—multiple sclerosis	0.00015	0.000188	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—MMP9—multiple sclerosis	0.000148	0.000186	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—MAPK1—multiple sclerosis	0.000147	0.000185	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—STAT3—multiple sclerosis	0.000142	0.000178	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—MYC—multiple sclerosis	0.000132	0.000165	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—STAT3—multiple sclerosis	0.000132	0.000165	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—TGFB1—multiple sclerosis	0.000131	0.000165	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—MAPK1—multiple sclerosis	0.000129	0.000161	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—MYC—multiple sclerosis	0.000122	0.000153	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—TGFB1—multiple sclerosis	0.000122	0.000153	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—IL6—multiple sclerosis	0.000121	0.000152	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—MAPK1—multiple sclerosis	0.00012	0.00015	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—IL6—multiple sclerosis	0.000113	0.000142	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—IL6—multiple sclerosis	9.89e-05	0.000124	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—IL6—multiple sclerosis	9.19e-05	0.000115	CbGpPWpGaD
